Apollo Hospitals Enterprise has entered into collaboration with Medtronic, Inc., the global leader in medical technology, to bring to market an innovative, affordable and portable hemodialysis system in India. This would help improve access to care for End Stage Renal Disease (ESRD) patients who need Renal Replacement Therapy (RRT).
This collaboration will leverage a Medtronic-developed technology platform, supported by clinical insight from Apollo envisioning a cost reduction by 10-20 per cent for patients. At present, on an average a patient spends about Rs 1,200 to Rs 2,000 for a dialysis.
Medtronic intends to develop and manufacture key components of this hemodialysis system in India which will be ready for commercial launch in 2016.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: